Literature DB >> 27311400

Head and neck intensity modulated radiation therapy leads to an increase of opportunistic oral pathogens.

Jennifer M Schuurhuis1, Monique A Stokman2, Max J H Witjes1, Johannes A Langendijk3, Arie J van Winkelhoff4, Arjan Vissink1, Frederik K L Spijkervet5.   

Abstract

OBJECTIVES: The introduction of intensity modulated radiation therapy (IMRT) has led to new possibilities in the treatment of head and neck cancer (HNC). Limited information is available on how this more advanced radiation technique affects the oral microflora. In a prospective study we assessed the effects of various advanced treatments for HNC on the oral microflora, as well as the effects of elimination of oral foci of infection.
MATERIALS AND METHODS: All consecutive dentate patients >18years, diagnosed with a primary oral or oropharynx carcinoma and seen for a pre-treatment dental screening (May 2011-May 2013) were included. Patients were grouped by oncologic treatment: surgery (SURG), IMRT (IMRT) or IMRT+chemotherapy (CHIMRT). Dental screening data, demographic data, subgingival biofilm samples, oral lavages and whole saliva samples were obtained to microbiologically analyze the effects of cancer treatments (1-year follow-up).
RESULTS: This study included 82 patients (29 SURG, 26 IMRT and 27 CHIMRT). The trends in changes in prevalence and proportions of microorganisms were comparable in the IMRT and CHIMRT group. However, relative to the SURG group, increased prevalence of enteric rods, staphylococci and Candida species was observed in the IMRT and CHIMRT groups. In these groups, elimination of oral foci decreased the frequency of detection of pathogens such as Porphyromonas gingivalis, Tannerella forsythia and Streptococcus mutans.
CONCLUSION: Different treatments in HNC patients result in different changes in the oral microflora. Opportunistic pathogens such as staphylococci, enteric rods and Candida sp. tend to increase in prevalence after IMRT with or without chemotherapy, but not after surgical intervention.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chemoradiotherapy; Head and neck neoplasms; Intensity modulated radiotherapy; Microbiota; Periodontitis

Mesh:

Year:  2016        PMID: 27311400     DOI: 10.1016/j.oraloncology.2016.05.005

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  14 in total

1.  Salivary Metabolomics of Total Body Irradiated Nonhuman Primates Reveals Long-Term Normal Tissue Responses to Radiation.

Authors:  Evagelia C Laiakis; Denise Nishita; Kim Bujold; Meth M Jayatilake; James Bakke; Janet Gahagen; Simon Authier; Polly Chang; Albert J Fornace
Journal:  Int J Radiat Oncol Biol Phys       Date:  2019-07-25       Impact factor: 7.038

2.  Evaluation of Alteration in Oral Microbial Flora Pre- and Postradiation Therapy in Patients with Head and Neck Cancer.

Authors:  Ayanambakkam Hemasundar Harini Priya; Hari Priya Arun Kumar; Shakthi Akash Raj; Sai Archana; Bharathwaj Venkatanarasu
Journal:  J Pharm Bioallied Sci       Date:  2020-08-28

Review 3.  Oral-Gut Microbiome Axis in Gastrointestinal Disease and Cancer.

Authors:  Se-Young Park; Byeong-Oh Hwang; Mihwa Lim; Seung-Ho Ok; Sun-Kyoung Lee; Kyung-Soo Chun; Kwang-Kyun Park; Yinling Hu; Won-Yoon Chung; Na-Young Song
Journal:  Cancers (Basel)       Date:  2021-04-28       Impact factor: 6.639

4.  Patients with advanced periodontal disease before intensity-modulated radiation therapy are prone to develop bone healing problems: a 2-year prospective follow-up study.

Authors:  Jennifer M Schuurhuis; Monique A Stokman; Max J H Witjes; Harry Reintsema; Johannes A Langendijk; Arjan Vissink; Frederik K L Spijkervet
Journal:  Support Care Cancer       Date:  2017-10-31       Impact factor: 3.603

5.  Caries-associated oral microbiome in head and neck cancer radiation patients: a longitudinal study.

Authors:  Jean-Luc C Mougeot; Craig B Stevens; Kathryn G Almon; Bruce J Paster; Rajesh V Lalla; Michael T Brennan; Farah Bahrani Mougeot
Journal:  J Oral Microbiol       Date:  2019-03-08       Impact factor: 5.474

Review 6.  Clinical update on head and neck cancer: molecular biology and ongoing challenges.

Authors:  Elham Alsahafi; Katheryn Begg; Ivano Amelio; Nina Raulf; Philippe Lucarelli; Thomas Sauter; Mahvash Tavassoli
Journal:  Cell Death Dis       Date:  2019-07-15       Impact factor: 8.469

Review 7.  Should oral foci of infection be removed before the onset of radiotherapy or chemotherapy?

Authors:  Fred K L Spijkervet; Jennifer M Schuurhuis; Monique A Stokman; Max J H Witjes; Arjan Vissink
Journal:  Oral Dis       Date:  2020-06-01       Impact factor: 3.511

Review 8.  Periodontal therapy for patients before and after radiotherapy: A review of the literature and topics of interest for clinicians.

Authors:  M-S Irie; E-M Mendes; J-S Borges; L-G-G Osuna; G-D Rabelo; P-B-F Soares
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2018-09-01

9.  Dental approach of orofacial pain in head and neck cancer patients.

Authors:  Diele Arantes; Náira Costa; Tacyana Resende; Karina Mikulas; Pierre da Silva Júnior; Rafael Brito; Vladimir Noronha; Roberto Pedras; Luciana Corrêa
Journal:  J Clin Exp Dent       Date:  2018-11-01

Review 10.  Evidence-Based Support for Nutrition Therapy in Head and Neck Cancer.

Authors:  Ryan Nesemeier; Neal Dunlap; Stephen A McClave; Paul Tennant
Journal:  Curr Surg Rep       Date:  2017-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.